{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:12:18Z","timestamp":1793905938862,"version":"4.8.0"},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA041034"],"award-info":[{"award-number":["R01DA041034"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24DA035684"],"award-info":[{"award-number":["K24DA035684"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI102623"],"award-info":[{"award-number":["T32AI102623"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP1DA060602"],"award-info":[{"award-number":["DP1DA060602"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Int AIDS Soc."],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Long\u2010acting injectable (LAI) antiretroviral therapy (ART) and pre\u2010exposure prophylaxis (PrEP) have significant potential to impact the HIV epidemic, but there is little data on the acceptability of these newer technologies among people who inject drugs (PWID) and men who have sex with men (MSM) in low\u2010resource settings. We examined acceptability and preferences of LAI ART and PrEP among community\u2010based samples of PWID and MSM in India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross\u2010sectional survey of PWID and MSM in eight Indian cities (November 2022\u2212May 2024) using respondent\u2010driven sampling. Participants completed a survey including socio\u2010demographics, substance use, risk behaviours, HIV testing\/care history, acceptability of LAI ART and knowledge, acceptability, and preferences of different PrEP modalities (i.e. daily oral, monthly oral, LAI and implant). We assessed correlates of acceptability using Poisson regression models. To understand PrEP preferences, we used a modified Borda count method\u2014a rank voting procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 2249 MSM and 4499 PWID (98% male) were recruited. Among those previously diagnosed with HIV, 89% (MSM) and 75% (PWID) reported a very good chance they would use LAI ART. MSM experiencing unstable housing and PWID virally suppressed were more willing to use LAI ART. Twenty percent and five percent of MSM and PWID, respectively, had ever heard of PrEP. Among those without an HIV diagnosis, 77% (MSM) and 62% (PWID) reported a very good chance they would use LAI PrEP. MSM with more sexual partners and sexually transmitted infection symptoms and PWID who had heard of PrEP were more willing to use LAI PrEP. Among MSM interested in PrEP, monthly oral pills were most preferred, followed by LAI, daily oral pills and then implant. Among PWID, monthly oral pills were most preferred, followed by daily oral pills, LAI and then implant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MSM and PWID in India were open and interested in LAI ART and PrEP. Once these become available, programmes with thoughtful community outreach and education, alongside flexible delivery models, will be critical to success. For PrEP, continued investment in the development of extended\u2010duration oral formulations is warranted and valuable in order to provide a variety of HIV prevention choices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jia2.70114","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:47:06Z","timestamp":1777448826000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acceptability and Preferences of Long\u2010Acting Injectable Pre\u2010Exposure Prophylaxis and Antiretroviral Therapy Among Men Who Have Sex With Men and People Who Inject Drugs in India: Insights for Future Implementation"],"prefix":"10.1002","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1157-2931","authenticated-orcid":false,"given":"Allison M.","family":"McFall","sequence":"first","affiliation":[{"name":"Department of Epidemiology Johns Hopkins University Bloomberg School of Public Health  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia A.","family":"Loeb","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Johns Hopkins University Bloomberg School of Public Health  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiban J.","family":"Baishya","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Johns Hopkins University School of Medicine  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Kedar","sequence":"additional","affiliation":[{"name":"Y.R. Gaitonde Centre for AIDS Research and Education (YRGCARE)  Chennai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archit","family":"Sinha","sequence":"additional","affiliation":[{"name":"Y.R. Gaitonde Centre for AIDS Research and Education (YRGCARE)  Chennai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Srikrishnan","sequence":"additional","affiliation":[{"name":"Y.R. Gaitonde Centre for AIDS Research and Education (YRGCARE)  Chennai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil S.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Johns Hopkins University School of Medicine  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Lucas","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Johns Hopkins University School of Medicine  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti H.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Johns Hopkins University Bloomberg School of Public Health  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003102"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa552"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30097-3"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(22)00365-4"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25427"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00079-6"},{"key":"e_1_2_11_8_1","unstructured":"A. I.Rana Y.Bao andL.Zheng et\u00a0al. \u201cLong\u2010Acting Injectable CAB\/RPV Is Superior to Oral ART in PWH With Adherence Challenges: ACTG A5359 \u201d inConference on Retroviruses and Opportunistic Infections(2024)."},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407001"},{"key":"e_1_2_11_10_1","article-title":"Twice\u2010Yearly Lenacapavir for HIV Prevention in Cisgender Gay, Bisexual, and Other Men, Transgender Women, Transgender Men, and Gender\u2010Nonbinary People Who Have Sex With Partners Assigned Male at Birth: Interim Analysis Results From the PURPOSE 2 Study","author":"Kelley C. F.","year":"2024","journal-title":"HIVR49"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00538-4"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101016"},{"key":"e_1_2_11_13_1","unstructured":"World Health Organization HIV Data and Statistics\u2014HIV\u2014Number of People Living With HIV(2025);https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator\u2010details\/GHO\/estimated\u2010number\u2010of\u2010people\u2013living\u2010with\u2010hiv. Accessed April 2 2015."},{"key":"e_1_2_11_14_1","volume-title":"Sankalak: Status of National AIDS & STD Response","author":"National AIDS Control Organisation","year":"2023"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26361"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(21)00098-9"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2022.2119470"},{"key":"e_1_2_11_18_1","article-title":"People Who Inject Drugs and Men Who Have Sex With Men Living With HIV in India Experience Low Probability of Viral Rebound and High Levels of Persistent Viremia During the First 12 Months of Antiretroviral Therapy","author":"Loeb T. A.","journal-title":"AIDS Care"},{"key":"e_1_2_11_19_1","volume-title":"National Guidelines for HIV Care and Treatment, 2021","author":"National AIDS Control Organisation","year":"2021"},{"key":"e_1_2_11_20_1","unstructured":"National AIDS Control Organisation India HIV Estimates. Technical Report(2010)."},{"key":"e_1_2_11_21_1","unstructured":"Office of Registrar General & Census Commissioner\u2014India Census Tables(2011);https:\/\/censusindia.gov.in\/census.website\/data\/census\u2010tables. Accessed June 1 2024."},{"key":"e_1_2_11_22_1","volume-title":"Modified Borda Count","author":"The de Borda Institute","year":"2025"},{"key":"e_1_2_11_23_1","unstructured":"Y.Kapoor B.Evans andR. P.Carstens \u201cMK\u20108527 PK\/PD Threshold and Phase 2 Dose Selection for Monthly Oral HIV\u20101 Preexposure Prophylaxis \u201d inConference on Retroviruses and Opportunistic Infections (CROI) San Francisco California(2025)."},{"key":"e_1_2_11_24_1","volume-title":"PrEPWatch Country Overview, India","author":"AVAC","year":"2025"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.5713"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25664"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-021-03253-5"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0001477"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247352"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-024-04285-3"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.16.1789"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.70114","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jia2.70114","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.70114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:07:48Z","timestamp":1783116468000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.70114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1002\/jia2.70114"],"URL":"https:\/\/doi.org\/10.1002\/jia2.70114","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"2025-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70114"}}